Botswana vs Myanmar: Average cost of drugs for extensively drug-resistant tuberculosis

Botswana

900 constant 2022 US$

in 2024

Myanmar

963 constant 2022 US$

in 2024

Botswana rank

44th

Myanmar rank

43rd

Average cost of drugs for extensively drug-resistant tuberculosis over time

Myanmar currently reports 963 constant 2022 US$ against 900 constant 2022 US$ in Botswana, a difference of 63 constant 2022 US$.

That makes Myanmar's figure about 1.1 times Botswana's.

The two have swapped places 1 time across 5 shared years of data; in 2017 it was Botswana ahead.

Botswana ranks 44th and Myanmar ranks 43rd of 56 countries.

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.